Preferred Label : galcanezumab;
MeSH hyponym : LY-2951742;
UNII : 55KHL3P693;
Origin ID : C000628360;
UMLS CUI : C4694273;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.cbip.be/fr/articles/3752?folia=3740
2022
false
false
false
Belgium
French
journal article
raynaud phenomenon
migraine disorders
erenumab
fremanezumab
galcanezumab
calcitonin gene-related peptide
cohort studies
Calcitonin gene-related peptide (CGRP) antagonists
disease progression
---
https://www.cbip.be/fr/articles/3662?folia=3658
2021
false
false
false
Belgium
French
journal article
drug information
antibodies, monoclonal, humanized
migraine disorders
antibodies, monoclonal
belgium
calcitonin gene-related peptide
erenumab
fremanezumab
galcanezumab
---
https://www.has-sante.fr/jcms/p_3191463/fr/emgality
2020
false
false
false
France
insurance, health, reimbursement
treatment outcome
galcanezumab
galcanezumab
galcanezumab
injections, subcutaneous
antibodies, monoclonal, humanized
migraine disorders
Product containing only galcanezumab in parenteral dose form (medicinal product form)
antibodies, monoclonal, humanized
evaluation of the transparency committee
antibodies, monoclonal
antibodies, monoclonal
---
https://www.ema.europa.eu/en/medicines/human/EPAR/emgality
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
galcanezumab
galcanezumab
adult
migraine disorders
injections, subcutaneous
calcitonin gene-related peptide
product surveillance, postmarketing
pregnancy
breast feeding
drug evaluation, preclinical
galcanezumab
antibodies, monoclonal
antibodies, monoclonal
---